Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
April-2016 Volume 11 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2016 Volume 11 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells

  • Authors:
    • Peiyan Hua
    • Guangxin Zhang
    • Yifan Zhang
    • Mei Sun
    • Ranji Cui
    • Xin Li
    • Bingjin Li
    • Xingyi Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Department of Pathology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Jilin Provincial Key Laboratory of Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Jilin Provincial Key Laboratory of Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
  • Pages: 2780-2786
    |
    Published online on: March 1, 2016
       https://doi.org/10.3892/ol.2016.4295
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Despite the availability of several therapeutic options, a safer and more effective modality strategy is required for the treatment of lung cancer. Costunolide, a sesquiterpene lactone which isolated from the Saussurea lappa, has potent anticancer properties. In the present study, the effects of costunolide on cell viability, the cell cycle and apoptosis in SK‑MES‑1 human lung squamous carcinoma cells were investigated. Costunolide induced morphological changes and inhibited growth of SK‑MES‑1 cells growth. Flow cytometric analysis data demonstrated that costunolide significantly induced apoptosis of SK‑MES‑1 cells and induced cell cycle arrest at G1/S phase in a dose‑dependent manner. Through upregulation in the expression of p53 and Bax, and downregulation in the expression of Bcl‑2 and activation of caspase‑3, costunolide‑induced apoptosis was confirmed by western blot analysis. In addition, the significant loss of mitochondrial membrane potential indicated that costunolide may induce apoptosis via the mitochondria‑dependent pathway in SK‑MES‑1 cells. These results highlight the potential effects of costunolide as an anti‑cancer agent in a human lung squamous carcinoma cell line.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Saba NF and Khuri FR: Chemoprevention strategies for patients with lung cancer in the context of screening. Clin Lung Cancer. 7:92–99. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Chou JY, Lai SY, Pan SL, Jow GM, Chern JW and Guh JH: Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. Biochem Pharmacol. 66:115–124. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Bonomi P, Kim K, Fairclough D, Cella D, Kugler J, Rowinsky E, Jiroutek M and Johnson D: Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial. J Clin Oncol. 18:623–631. 2000.PubMed/NCBI

5 

Lin Y, Xu J, Liao H, Li L and Pan L: Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway. Tumour Biol. 35:3305–3310. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Rasul A, Bao R, Malhi M, Zhao B, Tsuji I, Li J and Li X: Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction. Molecules. 18:1418–1433. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Bonomi P: Review of paclitaxel/carboplatin in advanced non-small cell lung cancer. Semin Oncol. 26(Suppl 2): S55–S59. 1999.

8 

Gu JQ, Gills JJ, Park EJ, Mata-Greenwood E, Hawthorne ME, Axelrod F, Chavez PI, Fong HH, Mehta RG, Pezzuto JM and Kinghorn AD: Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity. J Natl Prod. 65:532–536. 2002. View Article : Google Scholar

9 

Koch E, Klaas CA, Rüngeler P, Castro V, Mora G, Vichnewski W and Merfort I: Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB. Biochem Pharmacol. 62:795–801. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Robles M, Aregullin M, West J and Rodriguez E: Recent studies on the zoopharmacognosy, pharmacology and neurotoxicology of sesquiterpene lactones. Planta Med. 61:199–203. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Park HJ, Jung WT, Basnet P, Kadota S and Namba T: Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J Nat Prod. 59:1128–1130. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Wedge DE, Galindo JC and Macías FA: Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry. 53:747–757. 2000. View Article : Google Scholar : PubMed/NCBI

13 

Chen HC, Chou CK, Lee SD, Wang JC and Yeh SF: Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res. 27:99–109. 1995. View Article : Google Scholar : PubMed/NCBI

14 

Koo TH, Lee JH, Park YJ, Hong YS, Kim HS, Kim KW and Lee JJ: A sesquiterpene lactone, costunolide, from Magnolia grandiflora inhibits NF-kappa B by targeting I kappa B phosphorylation. Planta Med. 67:103–107. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Fukuda K, Akao S, Ohno Y, Yamashita K and Fujiwara H: Inhibition by costunolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Cancer Lett. 164:7–13. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Choi JH, Ha J, Park JH, Lee JY, Lee YS, Park HJ, Choi JW, Masuda Y, Nakaya K and Lee KT: Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn J Cancer Res. 93:1327–1333. 2002. View Article : Google Scholar : PubMed/NCBI

17 

Kim SH, Kang SN, Kim HJ and Kim TS: Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone. Biochem Pharmacol. 64:1233–1242. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Choi YK, Cho SG, Woo SM, Yun YJ, et al: Saussurea lappa clarke-derived costunolide prevents TNF α-induced breast cancer cell migration and invasion by inhibiting NF-κB activity. Evid Based Complement Alternat Med. 2013:9362572013. View Article : Google Scholar : PubMed/NCBI

19 

Choi YK, Seo HS, Choi HS, Choi HS, Kim SR, Shin YC and Ko SG: Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231. Mol Cell Biochem. 363:119–128. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Liu CY, Chang HS, Chen IS, Chen CJ, Hsu ML, Fu SL and Chen YJ: Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells. Radiat Oncol. 6:562011. View Article : Google Scholar : PubMed/NCBI

21 

Hsu JL, Pan SL, Ho YF, Hwang TL, Kung FL and Guh JH: Costunolide induces apoptosis through nuclear calcium2+ overload and DNA damage response in human prostate cancer. J Urol. 185:1967–1974. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Choi JH and Lee KT: Costunolide-induced apoptosis in human leukemia cells: Involvement of c-jun N-terminal kinase activation. Biol Pharm Bull. 32:1803–1808. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Choi SH, Im E, Kang HK, Lee JH, Kwak HS, Bae YT, Park HJ and Kim ND: Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Lett. 227:153–162. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Komiya T, Yamada Y, Moteki H, Katsuzaki H, Imai K and Hibasami H: Hot water soluble sesquiterpenes [anhydroperoxy-costunolide and 3-oxoeudesma-1,4 (15),11 (13)triene-12,6alpha-olide] isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia cells. Oncol Rep. 11:85–88. 2004.PubMed/NCBI

25 

Hibasami H, Yamada Y, Moteki H, Katsuzaki H, Imai K, Yoshioka K and Komiya T: Sesquiterpenes (costunolide and zaluzanin D) isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia HL-60 cells. Int J Mol Med. 12:147–151. 2003.PubMed/NCBI

26 

Kretschmer N, Rinner B, Stuendl N, Kaltenegger H, Wolf E, Kunert O, Boechzelt H, Leithner A, Bauer R and Lohberger B: Effect of costunolide and dehydrocostus lactone on cell cycle, apoptosis and ABC transporter expression in human soft tissue sarcoma cells. Planta Med. 78:1749–1756. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Yang YI, Kim JH and Choi JH: Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Gynecol Oncol. 123:588–596. 2011. View Article : Google Scholar : PubMed/NCBI

28 

King KL and Cidlowski JA: Cell cycle regulation and apoptosis. Ann Rev Physiol. 60:601–617. 1998. View Article : Google Scholar

29 

Collins K, Jacks T and Pavletich NP: The cell cycle and cancer. Proc Natl Acad Sci USA. 94:2776–2778. 1997. View Article : Google Scholar : PubMed/NCBI

30 

Pan J, She M, Xu ZX, Sun L and Yeung SC: Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res. 65:3671–3681. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Bergamo A, Gagliardi R, Scarcia V, Furlani A, Alessio E, Mestroni G and Sava G: In vitro cell cycle arrest, in vivo action on solid metastasizing tumors and host toxicity of the antimetastatic drug NAMI-A and cisplatin. J Pharmacol Exp Ther. 289:559–564. 1999.PubMed/NCBI

32 

Horwitz SB: Taxol (paclitaxel): Mechanisms of action. Ann Oncol. 5(Suppl 6): S3S61994.

33 

Fridman JS and Lowe SW: Control of apoptosis by p53. Oncogene. 22:9030–9040. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Budram-Mahadeo V, Morris PJ and Latchman DS: The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1). Oncogene. 21:6123–6131. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Tchernev G and Orfanos CE: Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: Preliminary findings. J Cutan Pathol. 34:247–256. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22. 1994. View Article : Google Scholar : PubMed/NCBI

37 

Rasul A, Ding C, Li X, Khan M, Yi F, Ali M and Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB activation, up-regulates the expression of p53 and enhances apoptosis. Apoptosis. 17:1104–1119. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Sakuragi N, Salah-eldin AE, Watari H, Itoh T, Inoue S, Moriuchi T and Fujimoto S: Bax, Bcl-2 and p53 expression in endometrial cancer. Gynecol Oncol. 86:288–296. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Frenzel A, Grespi F, Chmelewskij W and Villunger A: Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 14:584–596. 2009. View Article : Google Scholar : PubMed/NCBI

40 

Ly JD, Grubb DR and Lawen A: The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 8:115–128. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Porter AG and Jünicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hua P, Zhang G, Zhang Y, Sun M, Cui R, Li X, Li B and Zhang X: Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells. Oncol Lett 11: 2780-2786, 2016.
APA
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X. ... Zhang, X. (2016). Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells. Oncology Letters, 11, 2780-2786. https://doi.org/10.3892/ol.2016.4295
MLA
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X., Li, B., Zhang, X."Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells". Oncology Letters 11.4 (2016): 2780-2786.
Chicago
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X., Li, B., Zhang, X."Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells". Oncology Letters 11, no. 4 (2016): 2780-2786. https://doi.org/10.3892/ol.2016.4295
Copy and paste a formatted citation
x
Spandidos Publications style
Hua P, Zhang G, Zhang Y, Sun M, Cui R, Li X, Li B and Zhang X: Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells. Oncol Lett 11: 2780-2786, 2016.
APA
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X. ... Zhang, X. (2016). Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells. Oncology Letters, 11, 2780-2786. https://doi.org/10.3892/ol.2016.4295
MLA
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X., Li, B., Zhang, X."Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells". Oncology Letters 11.4 (2016): 2780-2786.
Chicago
Hua, P., Zhang, G., Zhang, Y., Sun, M., Cui, R., Li, X., Li, B., Zhang, X."Costunolide induces G1/S phase arrest and activates mitochondrial‑mediated apoptotic pathways in SK‑MES 1 human lung squamous carcinoma cells". Oncology Letters 11, no. 4 (2016): 2780-2786. https://doi.org/10.3892/ol.2016.4295
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team